← Eichor
Study identifier: NCT07448584 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Lok™ Suture Anchors Safety & Performance Trial

Condition: Rotator Cuff Tears of the Shoulder · Labrum Injury  ·  Sponsor: Move Up SAS

PhaseNA
Planned participants216
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this study is to evaluate the performance and safety of Move-Up's lok™ system (lok™ suture anchors range and associated instrumentation). These devices will be evaluated at approximately 3, 6 and 12 months with 3 scoring criteria: Constant score, VAS pain score, and subjective shoulder value score (SSV). At the 6-month and 12-month post-operative visit, tendon healing, and the absence of recurrence of rupture or failure to heal in patients treated with lok™ anchors will also be analyzed. The Sugaya score on ultrasound imaging will be used for this assessment. Adverse Events (AEs) and Serious Adverse Events (SAEs) will be assessed after the surgery and at each follow-up (1, 3, 6 and 12 months after the surgery).

This description comes directly from the study's public registry record.

Talk to the study team

Manal OUBOUKHA, Clinical affairs manager  ·  33 677 096 697  ·  manal.ouboukha@move-ortho.com

Always discuss trial participation with your own doctor first.

Locations (1)

AlixanValence, Auvergne-Rhône-Alpes, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07448584